Abstract
Introduction Pretreatment loss to follow-up (PTLFU)—dropout of patients after diagnosis but before registration in treatment—is a major gap in TB care delivery in India and globally. Patient and healthcare worker (HCW) perspectives are critical for developing interventions to address this problem.
Methods We prospectively tracked newly diagnosed smear-positive TB patients from 22 TB diagnostic centers in Chennai, one of India’s largest cities. Patients who did not start therapy within 14 days, or who died or were lost to follow-up before official registration in treatment, were classified as PTLFU cases. We conducted qualitative interviews with all trackable PTLFU patients, or family members of patients who had died. We conducted focus group discussions (FGDs) with three types of HCWs involved in TB care. Interview and FGD recordings were transcribed, coded, and analyzed with the support of Dedoose 8.0.35 software to identify key themes. We created categories into which these themes clustered, identified relationships among thematic categories, and assembled findings into a broader explanatory model for PTLFU.
Results We conducted six FGDs comprising 53 HCWs and 33 individual patient or family member interviews. Themes clustered into five categories. Examining relationships among these categories revealed two pathways leading to PTLFU as part of a broader explanatory model. In the first pathway, administrative and organizational health system barriers—including the complexity of navigating the system, healthcare worker absenteeism, and infrastructure failures—resulted in patients feeling frustration or resignation, leading to disengagement from care. Health system barriers experienced by patients were in turn shaped by constraints that made it difficult for HCWs to do their jobs effectively. In the second pathway, negative or judgmental HCW attitudes and behaviors towards patients contributed to patient distrust of the health system, resulting in refusal of further care.
Conclusion Health system barriers contribute substantially to PTLFU directly and by amplifying patient-related challenges to engaging in care. Interventions should focus on removing administrative hurdles patients face in the health system, improving the quality of the HCW-patient interaction, and alleviating constraints HCWs face in being able to provide optimal patient-centered care.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
RS and the field research team were supported by a Fogarty Global Health Equity Scholars Fellowship (NIAID R25 TW009338). RS also received support from a Harvard Catalyst KL2/Catalyst Medical Investigator Training Award (KL2 TR001100), a grant from the Bill and Melinda Gates Foundation via the Arcady Group (OPP1154665), and a Doris Duke Clinical Scientist Development Award. The funding bodies had no role in study design, data collection, data analysis, data interpretation, or manuscript writing.
Author Declarations
All relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
Any clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.
Yes
Data Availability
The qualitative data have not been included as a supplement to this manuscript because this would likely compromise the individual privacy of patients, as it may be possible to identify specific individuals based on the in-depth manuscripts. Requests for the de-identified qualitative dataset can be made by contacting Dr. Beena Thomas (beenathomas{at}nirt.res.in), although access to these data may be subject to review by the NIRT Institutional Ethics Committee.
List of Abbreviations
- CI
- confidence interval
- DMC
- designated microscopy center
- DOT
- directly observed therapy
- FGD
- focus group discussion
- HCW
- healthcare worker
- HV
- health visitor
- LT
- laboratory technician
- PTLFU
- pretreatment loss to follow-up
- RNTCP
- Revised National Tuberculosis Control Programme
- STS
- senior treatment supervisor
- TB
- tuberculosis
